Raremark has announced that it is rebranding as Xperiome. Jeremy Edwards, CEO of Xperiome, commented, “Strategically, we are rebranding because we have two very different audiences, with individual needs that will benefit from equal attention and focus.”
Xperiome will now become the name and corporate identity of the company, while the Raremark brand will solely represent its patient-facing activities dedicated to helping people better understand, talk about and manage rare diseases.
For more information, click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.